tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Graig Suvannavejh, 117 are a BUY (66.86%), 52 are a HOLD (29.71%), 6 are a SELL (3.43%).
Analyst Graig Suvannavejh, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 57.92% that have a potential upside of 32.47% achieved within 108 days. Previously, Graig Suvannavejh worked at MIZUHO.
Graig Suvannavejh’s has documented 369 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AUTL, Autolus Therapeutics Ltd at 18-Nov-2024.
Analyst best performing recommendations are on ADVM (ADVERUM BIOTECHNOLOGIES).
The best stock recommendation documented was for ADVM (ADVERUM BIOTECHNOLOGIES) at 4/28/2020. The price target of $170 was fulfilled within 7 days with a profit of $48.4 (39.8%) receiving and performance score of 56.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$3
$1.03 (52.28%)
$10
24 days ago
(26-Nov-2024)
1/6 (16.67%)
$0.4 (15.38%)
332
Buy
$5
$3.03 (153.81%)
$16
24 days ago
(26-Nov-2024)
1/3 (33.33%)
$2.4 (92.31%)
70
Buy
$35
$33.03 (1676.65%)
$35
1 months 13 days ago
(07-Nov-2024)
0/7 (0%)
$29.36 (520.57%)
Buy
$15
$13.03 (661.42%)
$8
1 years 6 days ago
(14-Dec-2023)
1/4 (25%)
$7 (87.50%)
128
Buy
$9
$7.03 (356.85%)
$10
1 years 1 months 3 days ago
(17-Nov-2023)
1/5 (20%)
$4.69 (108.82%)
24
Which stock is Graig Suvannavejh is most bullish on?
Which stock is Graig Suvannavejh is most reserved on?
What Year was the first public recommendation made by Graig Suvannavejh?
